Article
Endocrinology & Metabolism
Rinki Murphy, Lindsay D. Plank, Michael G. Clarke, Nicholas J. Evennett, James Tan, David D. W. Kim, Richard Cutfield, Michael W. C. Booth
Summary: SR-LRYGB provided superior diabetes remission and weight loss compared with LSG at 5 years, with similar low risks of complications.
Letter
Surgery
A. Chierici, N. Chevalier, A. Iannelli
Summary: Revisional bariatric surgery is becoming more popular as long-term follow-up studies show a high failure rate of primary surgery. This study aimed to determine the best revisional procedure after failure of primary restrictive surgery. The results showed that biliopancreatic diversion with duodenal switch and single-anastomosis duodenoileal bypass were the most effective procedures in terms of weight loss.
INTERNATIONAL JOURNAL OF SURGERY
(2022)
Article
Medicine, General & Internal
Brianna N. Lauren, Francesca Lim, Abraham Krikhely, Elsie M. Taveras, Jennifer A. Woo Baidal, Brandon K. Bellows, Chin Hur
Summary: This study evaluated the cost-effectiveness of medical therapy, sleeve gastrectomy (SG), and Roux-en-Y gastric bypass (RYGB) in patients with severe obesity and type 2 diabetes (T2D). The results showed that RYGB is the most cost-effective treatment strategy, resulting in the highest number of quality-adjusted life-years (QALYs) gained.
Article
Medicine, General & Internal
Regina Sierzantowicz, Jerzy R. Ladny, Krzysztof Kurek, Jolanta Lewko
Summary: This study aimed to analyze the pathologies on preoperative EGD in patients qualified for bariatric surgeries. The results showed that patients with obesity had a higher prevalence of esophageal pathologies compared to the control group, while the control group was more likely to have duodenal pathologies. Additionally, patient sex was a significant predictor of duodenal pathologies.
JOURNAL OF CLINICAL MEDICINE
(2021)
Article
Surgery
Hadrien Tranchart, Martin Gaillard, Radwan Kassir, Caroline Gronnier, David Moszkowicz, Imed Ben Amor, Panagiotis Lainas, Natalia Savala, Hugo Meunier, Yannick Le Roux, Olivier Degrandi, Clement Baratte, Karina Vychnevskaia, Jean Gugenheim, Ibrahim Dagher
Summary: This study examined the outcomes of patients diagnosed with malignancy before and after bariatric surgery in a French multisite cohort. The results showed that patients with a history of malignancy and those diagnosed with postoperative malignancy mainly had breast and gynecologic cancers. It was found that the weight loss outcomes one and two years after surgery were similar in both groups. Furthermore, the study suggests that a history of malignancy should not be considered an absolute contraindication for bariatric surgery.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2021)
Review
Surgery
Naveed Hossain, Chanpreet Arhi, Cynthia-Michelle Borg
Summary: Obesity is linked to worsened asthma outcomes, but bariatric surgery has shown to be effective in weight loss and asthma improvement. Compared to nonsurgical weight loss programs, bariatric surgery offers greater weight loss and more consistent improvement in asthma symptoms. However, more research is needed to study the effects of surgery on both mild and severe asthma cases.
Article
Medicine, General & Internal
Jean-Eric Tarride, Aristithes G. Doumouras, Dennis Hong, J. Michael Paterson, Semra Tibebu, Francis Nguyen, Richard Perez, Valerie H. Taylor, Feng Xie, Vanessa Boudreau, Eleanor Pullenayegum, David R. Urbach, Mehran Anvari
Summary: This study compared 4-year health care expenditures after RYGB and sleeve gastrectomy, finding no significant differences in all-cause mortality and number of hospital admissions between the two procedures, but more frequent nonelective hospitalizations with RYGB. Patients who underwent RYGB had a lower rate of subsequent bariatric procedures.
Article
Endocrinology & Metabolism
Marta Borges-Canha, Joao Sergio Neves, Fernando Mendonca, Maria Manuel Silva, Claudia Costa, Pedro M. Cabral, Vanessa Guerreiro, Rita Lourenco, Patricia Meira, Daniela Salazar, Maria Joao Ferreira, Jorge Pedro, Ebrahim Barkoudah, Ana Sande, Eva Lau, Selma B. Souto, John Preto, Paula Freitas, Davide Carvalho
Summary: This study aimed to evaluate the association between beta cell function and total body weight loss (TBWL%) 1 to 4 years after bariatric surgery in patients with morbid obesity. The results showed that baseline beta cell function was associated with long-term weight loss, especially after the first year post-surgery. This may be a helpful predictor of weight loss in clinical practice.
FRONTIERS IN ENDOCRINOLOGY
(2021)
Article
Nutrition & Dietetics
Karolina Hoffmann, Anna Paczkowska, Wieslaw Bryl, Kinga Marzec, Jonas Raakow, Matthias Pross, Rafael Berghaus, Elzbieta Nowakowska, Krzysztof Kus, Michal Michalak
Summary: This study compares the level of discrimination among obese patients in Poland and Germany and finds that obesity significantly affects the social and economic well-being of patients. The study suggests the need to reduce weight stigma and alleviate the socioeconomic and psychological burden of obesity.
Article
Endocrinology & Metabolism
Ville A. Palomaki, Petri Lehenkari, Sanna Merilainen, Tuomo J. Karttunen, Vesa Koivukangas
Summary: This case-control study analyzed the macrophage infiltration in subcutaneous adipose tissue after bariatric surgery or conservative treatment of obesity, and investigated whether these features could predict weight loss outcome. The study found a significant decline in crown-like structures (CLS) density after surgery, regardless of weight loss. However, surgery had no effect on the infiltration of single-cell macrophages, and the abundance of these macrophage populations before surgery did not predict weight loss or response to surgery.
Article
Surgery
Abbinaya Elangovan, Raj Shah, Zachary L. Smith
Summary: Despite a modest increase in the prevalence of anti-obesity medications in the last 10 years, they remain significantly underutilized, especially among adults with obesity. Further studies addressing the barriers to anti-obesity pharmacotherapy might help in increasing the utilization of these medications.
Article
Endocrinology & Metabolism
Eugene Lucas, Okeefe Simmons, Beverly Tchang, Louis Aronne
Summary: Although bariatric surgery leads to significant long-term weight loss, weight gain after surgery affects a considerable percentage of patients. Additionally, some patients experience inadequate weight loss. The effectiveness of anti-obesity medications for post-operative weight gain has not been firmly established yet due to varying study populations and designs. Observational studies consistently show the benefits of medical weight management after bariatric surgery, particularly with liraglutide, topiramate, and phentermine/topiramate, while new anti-obesity medications are expected to be helpful for post-surgical weight optimization.
FRONTIERS IN ENDOCRINOLOGY
(2023)
Article
Surgery
Nannan Li, Bei Xu, Jiangping Zeng, Shihui Lei, Lei Gu, Lijin Feng, Bing Zhu, Yueye Huang, Lu Wang, Lili Su, Shen Qu, Xiaoyun Cheng, Le Bu
Summary: This study evaluated the reliability of serum lipocalin-2 (LCN2) levels and other parameters as predictors of excellent weight loss one year after bariatric surgery. The results showed that preoperative LCN2 levels, waist circumference, and glycated hemoglobin were independent predictors of excellent weight loss.
Article
Surgery
Mohamed Abdelgawad, Ahmed Elgeidie, Mohamed El Sorogy, Mohamed Elrefai, Hosam Hamed, El-Sayed Abou El-Magd
Summary: This study aimed to investigate the long-term consequences of laparoscopic gastric plication (LGP) in obese patients. The results showed a significant reduction in BMI at 2 years, but a plateau at 3 and 4 years, with a significant BMI increase at 6 years. Weight regain was observed in 35 patients at the 6-year mark, resulting in a high rate of revisions. Predictors for weight regain included disrupted plication fold, increased hunger, and non-adherence to regular exercise.
Article
Surgery
Estella Y. Huang, Ryan C. Broderick, Jonathan Z. Li, Joaquin L. Serra, Pranav Ahuja, Samantha Wu, Michael Genz, Eduardo Grunvald, David C. Kunkel, Bryan J. Sandler, Santiago Horgan, Garth R. Jacobsen
Summary: Despite common assumptions, cannabis users did not experience inferior weight loss outcomes after bariatric surgery compared to non-users.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES
(2023)
